Lazard Asset Management’s MiMedx Group MDXG Stock Holding History
Bought
Maintained
Sold
Other funds holding MDXG
EWM
TI
NCM
PCMI
Lazard Asset Management's MDXG Position: Q2 2026 in Review
Lazard Asset Management reduced its MiMedx Group (MDXG) stake by 66% in Q2 2026, selling an estimated $1.02M and leaving 141,060 shares worth $543K. The position accounts for ﹤0.01% of the portfolio, ranked #1413.
Lazard Asset Management first reported a position in MDXG in Q1 2018 and has held it in 17 quarters since. The position peaked at $4.64M in Q4 2025. 226 funds tracked by Wall St. Rank hold MDXG as of Q2 2026.
- Lazard Asset Management held 141,060 shares of MiMedx Group worth $543K as of Q2 2026.
- Lazard Asset Management sold 279,646 MiMedx Group shares in Q2 2026, an estimated $1.02M.
- MiMedx Group made up ﹤0.01% of Lazard Asset Management's portfolio in Q2 2026, its #1413 holding.
- Lazard Asset Management first reported a position in MiMedx Group in Q1 2018 and has held it in 17 quarters since.
- Lazard Asset Management's MiMedx Group position peaked at $4.64M in Q4 2025.
- 226 funds tracked by Wall St. Rank held MiMedx Group as of Q2 2026.
Based on Lazard Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.